SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Analog Kid who wrote (782)1/3/1998 8:42:00 AM
From: Henry Volquardsen  Read Replies (1) of 1115
 
A.K.,

I think it was stated on the thread previously that the reason Lidak had not released the placebo comparison previously was at BMY's request. The NDA was a week prior to BMY cancelling the agreement so if there had been such an understanding between the two parties that would explain why the placebo comparison was not released at that time. Now that BMY has backed out of this agreement, if it ever existed, is now void. In that case I agree with others that I would like to see them release this comparison.

Ever since the initial phase 3 fiasco I have been wondering about this claim that the origional placebo was active. The thought crossed my mind as well that the healing time from Lidakol could be largely due to a psychosomatic boost. While I still have some concerns I do not believe there is a major psychosomatic factor and I believe the company is being honest about the origional placebo being active. My reason for coming to this conclusion is this, if herpes healing times can be effected by a patients expectations of relieve why then does acyclivir and the other treatments only decrease an outbreak by 1/2 day or so? If psychosomatic factors boost Lidakol why not the other ointments?

Lidak needs to come up with some answers.

Henry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News